Stay updated on Birinapant and Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Birinapant and Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Birinapant and Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The Locations section is reorganized under a single 'Locations' header listing states (Arizona, California, Florida, Maryland, Massachusetts, Pennsylvania, Texas). The discrete location entries (Arizona Locations, California Locations, Florida Locations, Maryland Locations, Massachusetts Locations, Pennsylvania Locations, Texas Locations) were removed, a 'Revision: v3.3.3' tag was added, and the 'HHS Vulnerability Disclosure' link was removed.
    Difference
    0.8%
    Check dated 2025-12-24T21:09:18.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    A minor site version update (Revision: v3.3.2) was implemented, with no visible changes to the study record.
    Difference
    0.1%
    Check dated 2025-11-25T10:48:13.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    A site-wide funding/operating status notice was removed from the page; this does not affect the trial details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:57:08.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The study status is updated to Terminated due to futility analysis, and enrollment has been stopped. The record now includes updated completion dates and results postings.
    Difference
    0.4%
    Check dated 2025-11-03T21:04:43.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Major change: updated operating status notice and version to v3.2.0, replacing v3.1.0; outlines funding lapse effects and where to check details.
    Difference
    3%
    Check dated 2025-10-06T05:40:58.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T03:09:00.000Z thumbnail image

Stay in the know with updates to Birinapant and Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Birinapant and Pembrolizumab in Solid Tumors Clinical Trial page.